Eecp India, enhanced external counterpulsation, treatment and therapy cost

22/10/2022

14/06/2019

Treatment of heart disease without Surgery

17/04/2018

The cardiothoracic surgeon ruled out Bypass Surgery He consulted other cardiologists and surgeons in Europe and the US, but all said the same thing Medical science cannot help you anymore.

But He Got Cured ! ! !

Dr Abdool Hamid Hoosen. This 51 yr old doctor from Johanesburg South Africa came to us with a history of having had 10 (TEN) stents implanted in his heart over the last 12 years.Now that no more…

11/03/2018

guys do suggest how we can improve our site http://eecpindia.com

01/10/2017

Role of EECP in Non-cardiac Conditions EECP has been tried in treatment of restless leg syndrome, erectile dysfunction, hepatorenal syndrome, Syndrome X, and retinal artery occlusion, although it is not FDA-approved for management of these conditions. EECP has been shown to improve transdermal oxygen concentration and concentration of moving red blood cells and significantly reduced transdermal carbon dioxide pressure and velocity of blood cells in healthy subjects probably due to peripheral vasodilatation.

Role of EECP in Non-cardiac Conditions EECP has been tried in treatment of restless leg syndrome, erectile dysfunction, hepatorenal syndrome, Syndrome X, and retinal artery occlusion, although it is…

01/10/2017

EECP in Acute Coronary Syndrome with Cardiogenic Shock A single-center, prospective study of ten patients with acute coronary syndrome and/or cardiogenic shock, ineligible for IABP counterpulsation, and received two to four 1-hour bedside treatments by portable EECP demonstrated a lack of portable EECP-related adverse effects like bleeding complications, heart failure exacerbation, skin breakdown, or interference with nursing care.29 EECP treatment resulted in significant increase in 30-minute mean arterial pressure compared to baseline (P=0.0002) and dyspnea severity (P=0.036) without significant changes in heart rate, pulse oximetry, or urine output. This study also suggests improved cardiovascular performance and possibly clinical outcomes with acute inpatient EECP in patients with acute coronary syndrome and cardiogenic shock.

EECP in Acute Coronary Syndrome with Cardiogenic Shock A single-center, prospective study of ten patients with acute coronary syndrome and/or cardiogenic shock, ineligible for IABP counterpulsation…

01/10/2017

Role of EECP in Hypertension A study of 108 consecutive patients receiving EECP demonstrated a significant (6.4 ± 16.2 mm Hg) reduction in systolic blood pressure at the end of therapy with no statistically significant effect on diastolic blood pressure or heart rate. Systolic blood pressure increased in the two lowest strata (

Role of EECP in Hypertension A study of 108 consecutive patients receiving EECP demonstrated a significant (6.4 ± 16.2 mm Hg) reduction in systolic blood pressure at the end of therapy with no…

01/10/2017

EECP Mechanism in Congestive Heart Failure Significant improvements in B-type natriuretic peptide, uric acid, free-T3/free-T4 ratio, and mitral annular E velocity have been observed in a prospective cohort study post-EECP therapy compared to baseline. EECP therapy has been shown to significantly increase LVEF and significantly reduce resting heart rate. EECP therapy has also been shown to be of benefit for patients with ischemic and non-ischemic cardiomyopathy, systolic or diastolic dysfunction. A study of 26 patients with heart failure (class II/III NYHA and average EF of 23%) showed clinical benefit without any major adverse cardiac effect.

EECP Mechanism in Congestive Heart Failure Significant improvements in B-type natriuretic peptide, uric acid, free-T3/free-T4 ratio, and mitral annular E velocity have been observed in a prospective…

01/10/2017

Role of EECP in Congestive Heart Failure Earlier studies have indicated a higher incidence of heart failure in patients with left ventricular dysfunction based on EECP increasing venous return and preload, hence precipitating pulmonary edema. The Prospective Evaluation of Enhanced External Counterpulsation in Congestive Heart failure (PEECH) trial of 187 subjects with stable, symptomatic, mild-to-moderate heart failure (left ventricular ejection fraction ≤35 %) on optimal medical management demonstrated a significant increase in exercise time of at least 60 seconds in the EECP group (35%) compared to control group (25%), with a significant improvement of the Minnesota Living with Heart Failure score at 1 week and 3 months after treatment. [ 136 more words ]

Role of EECP in Congestive Heart Failure Earlier studies have indicated a higher incidence of heart failure in patients with left ventricular dysfunction based on EECP increasing venous return and…